Michelle is the Founder, Chief Investment Officer, and Managing Partner of StemPoint Capital. She has over two decades of experience in healthcare investing covering public and private markets. Most recently, Michelle was a Partner and Portfolio Manager at Sphera Global Healthcare and Sphera Biotech Fund (2016-2022), managing approximately $1 billion in AUM at its peak in the fourth quarter of 2020. Previously, she spent three years at PointState Capital (2013-2016) as a Vice President covering the Biotherapeutics and Medical Technology sectors. Prior to that, Michelle was a global healthcare sector analyst at Soros Fund Management (2006-2013) and worked at Ursus Capital (2004-2005) covering the biopharmaceuticals industry. Michelle earned her B.S. in Biology at Stern College and earned her M.A. in Biotechnology from Columbia University where her thesis focused on Hematology and Molecular Medicine.